Hims & Hers Health (HIMS) Share-based Compensation (QoQ) (2020 - 2026)
Hims & Hers Health (HIMS) Share-based Compensation (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - |
| 10 | Hims & Hers Health | 8.57 Bn | 7.82 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.88% |
| Dec 31, 2025 | -14.15% |
| Sep 30, 2025 | 12.44% |
| Jun 30, 2025 | 43.72% |
| Mar 31, 2025 | 2.09% |
| Dec 31, 2024 | -2.21% |
| Sep 30, 2024 | 3.56% |
| Jun 30, 2024 | 26.32% |
| Mar 31, 2024 | 6.98% |
| Dec 31, 2023 | 2.98% |
| Sep 30, 2023 | 2.56% |
| Jun 30, 2023 | 18.90% |
| Mar 31, 2023 | 14.71% |
| Dec 31, 2022 | 12.49% |
| Sep 30, 2022 | 3.26% |
| Jun 30, 2022 | 20.05% |
| Mar 31, 2022 | -25.90% |
| Dec 31, 2021 | 0.70% |
| Sep 30, 2021 | 29.57% |
| Jun 30, 2021 | -73.24% |